JPRN-UMIN000024368已完成未知
Concurrent, daily-low-dose cisplatin-based chemoradiation in patients with cervical cancer, Exploratory Trial - Concurrent, daily-low-dose cisplatin-based chemoradiation in patients with cervical cancer, Exploratory Trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) positive para aortic lymph node swelling 2) severe systemic or uncontrolled disease (uncontrolled diabetes mellitus or hypertension) 3) severe infection that precluded the use of chemotherapy 4) preexisting neuropathy from any cause, pregnancy or lactation 5) mental illness 6) previous or concomitant malignancies
研究者
相似试验
已完成
2 期
Multicenter study of cisplatin-based chemotherapy with short hydration for lung cancer patientsung cancerJPRN-UMIN000010201ippon Medical School Hospital45
已完成
不适用
Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Phase II StudyHead and neck squamous cell carcinoma at stage III and IVJPRN-C000000273Department of Otolaryngology, Osaka University School of Medicine160
已完成
不适用
Dose-intensive weekly combination chemotherapy (cisplatin, vincristine, doxorubicin and etoposide) followed by cisplatin-etoposide therapy with concurrent thoracic irradiation: evaluation of a new treatment for limited-disease small-cell lung cancer.JPRN-C000000145West Japan Oncology Group20
已完成
2 期
Concomitant radiotherapy and weekly cisplatin with or without prior induction chemotherapy with cisplatin, epirubicin and paclitaxel (CEP) in patients with locally advanced nasopharyngeal carcinomaocally advanced nasopharyngeal carcinomaLocally advanced nasopharyngeal carcinomaCancer - Head and neckACTRN12609000730202Hellenic Cooperative Oncology Group148
已完成
不适用
Standard chemotherapy combination (Cyclophosphamide, Hydroxydaunorubicin, Vincristine, Prednisolone [CHOP]) with 1, 3 or 6 cycles of the monoclonal anti-CD20-antibody. Rituximab in first line therapy of follicular non-Hodgkin?s lymphoma.Follicular Lymphoma World Health Organisation (WHO) Grade I and II, Stage 3-4LymphomaCancerISRCTN47525145niversity of Heidelberg (Germany)120